Emtricitabine, Tenofovir disoproxil fumarate, and Efavirenz are used in the treatment of HIV infection.
How Emtricitabine, Tenofovir disoproxil fumarate, and Efavirenz work Emtricitabine, Tenofovir disoproxil fumarate, and Efavirenz is a combination of three antiviral medicines. They work by preventing HIV from multiplying, thereby reducing the amount of virus in your body. Additionally, they increase the CD4 cell count, which consists of white blood cells that protect against infection.
Common side effects of Emtricitabine, Tenofovir disoproxil fumarate, and Efavirenz include nausea, diarrhea, rash, allergic reaction, fatigue, decreased white blood cell count (neutrophils), vomiting, abdominal pain, increased transaminase levels in the blood, decreased phosphate levels in the blood, increased triglyceride levels in the blood, increased glucose levels in the blood, gastrointestinal disorders, increased liver enzymes, elevated serum amylase levels, increased lipase in the blood, elevated creatinine kinase, headache, insomnia, depression, dizziness, abnormal dreams, nasopharyngitis, upper respiratory tract infections, and anxiety.